José Luis Cortes-Altamirano , Alfonso Alfaro-Rodríguez , Abril Morraz-Varela , Samuel Reyes-Long
{"title":"Changes in gene expression of D2 and D5 receptors in the thalamus and midbrain caused by a persistent painful stimulus in Parkinsonian rats","authors":"José Luis Cortes-Altamirano , Alfonso Alfaro-Rodríguez , Abril Morraz-Varela , Samuel Reyes-Long","doi":"10.1016/j.neulet.2025.138270","DOIUrl":null,"url":null,"abstract":"<div><div>Pain is the most common and underdiagnosed non-motor symptom in Parkinson’s disease. Dopaminergic receptors D2 and D5 have been implicated in pain modulation. In this study, the expression of D2 and D5 receptors in the midbrain and thalamus in response to a painful stimulus was evaluated. The animals were assigned to a 6-OHDA group, a Sham group and a Control group. 6-OHDA was administered to the experimental group and 2 μl of 1 % ascorbic acid to the Sham group in the substantia nigra pars compacta. The midbrain and thalamus were dissected for RT-qPCR. In the formalin test, phase 1 showed significant differences between the Sham, 6-OHDA and Control groups, while in phase 2 the 6-OHDA group presented a greater nociceptive response. In the cylinder test, the 6-OHDA group showed a reduction in the use of the left limb and both limbs. In the open-field test, the 6-OHDA group spent more time in corners and showed less exploration in the periphery and center. An increasing trend for D5 was observed in the midbrain of the 6-OHDA group and in the thalamus of the Sham group. Dopaminergic injury induced by 6-OHDA as part of the parkinsonian model alters motor function, increases anxiety, and increases nociceptive response in the persistent phase of the formalin model. In addition, a non-significant increase in D5 receptor expression in the midbrain and thalamus may suggest an adaptive response of dopaminergic signaling to persistent pain.</div></div>","PeriodicalId":19290,"journal":{"name":"Neuroscience Letters","volume":"859 ","pages":"Article 138270"},"PeriodicalIF":2.5000,"publicationDate":"2025-05-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Neuroscience Letters","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S0304394025001582","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"NEUROSCIENCES","Score":null,"Total":0}
引用次数: 0
Abstract
Pain is the most common and underdiagnosed non-motor symptom in Parkinson’s disease. Dopaminergic receptors D2 and D5 have been implicated in pain modulation. In this study, the expression of D2 and D5 receptors in the midbrain and thalamus in response to a painful stimulus was evaluated. The animals were assigned to a 6-OHDA group, a Sham group and a Control group. 6-OHDA was administered to the experimental group and 2 μl of 1 % ascorbic acid to the Sham group in the substantia nigra pars compacta. The midbrain and thalamus were dissected for RT-qPCR. In the formalin test, phase 1 showed significant differences between the Sham, 6-OHDA and Control groups, while in phase 2 the 6-OHDA group presented a greater nociceptive response. In the cylinder test, the 6-OHDA group showed a reduction in the use of the left limb and both limbs. In the open-field test, the 6-OHDA group spent more time in corners and showed less exploration in the periphery and center. An increasing trend for D5 was observed in the midbrain of the 6-OHDA group and in the thalamus of the Sham group. Dopaminergic injury induced by 6-OHDA as part of the parkinsonian model alters motor function, increases anxiety, and increases nociceptive response in the persistent phase of the formalin model. In addition, a non-significant increase in D5 receptor expression in the midbrain and thalamus may suggest an adaptive response of dopaminergic signaling to persistent pain.
期刊介绍:
Neuroscience Letters is devoted to the rapid publication of short, high-quality papers of interest to the broad community of neuroscientists. Only papers which will make a significant addition to the literature in the field will be published. Papers in all areas of neuroscience - molecular, cellular, developmental, systems, behavioral and cognitive, as well as computational - will be considered for publication. Submission of laboratory investigations that shed light on disease mechanisms is encouraged. Special Issues, edited by Guest Editors to cover new and rapidly-moving areas, will include invited mini-reviews. Occasional mini-reviews in especially timely areas will be considered for publication, without invitation, outside of Special Issues; these un-solicited mini-reviews can be submitted without invitation but must be of very high quality. Clinical studies will also be published if they provide new information about organization or actions of the nervous system, or provide new insights into the neurobiology of disease. NSL does not publish case reports.